Since 2011, the COMET Clinical Trials Consortium has been funded by unrestricted educational grants from:
Current Sponsors (2018-2019):
TAIHO Pharma Canada, Inc.
Taiho Pharma Canada, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, they evolve with it—bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents. Advanced technology, dedicated investigators, and incomparable facilities—these vast resources empower us to redefine the way the world treats cancer.
Hoffmann-La Roche Ltd.
At Roche, our primary objective is to provide healthcare solutions that deliver superior options for diagnosis and treatment to clinicians and patients. As one of the world’s leading healthcare companies with combined strengths in pharmaceuticals and diagnostics, no company is better suited for this task.
At AbbVie, we have the expertise and structure of a proven pharmaceutical leader, and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today—a company that has the ability to discover and reach all corners of the globe with treatment options that can improve people’s lives.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
Amgen Canada strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.
At Celgene, we believe that a commitment to medical progress achieved through innovative science and life-enhancing new therapies must go hand in hand with a corresponding promise to ensure that patients who can benefit from our discoveries have the opportunity to do so.
AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialization of primary care, specialty care-led and specialty care medicines that transform lives.
Pfizer Canada Inc.
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines, vaccines and consumer health products. Their diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
Novartis Pharmaceuticals Inc.
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care products, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools.